Auriga
Auriga USA is a research and trading platform that focuses on growth sectors within the Health Care and Technology verticals. We operate out of our main office in New York City, and also have satellite offices in Boston, San Francisco, Philadelphia, San Diego, and Washington D.C. This regional network helps us to keep abreast of key corporate developments, enhance client relationships, and provide more efficient product distribution to meet clients' investment needs. The firm is committed to providing our clients with critical information flow, investment ideas, and access to industry experts.
-
Notable Analyst Rating Changes 04/14: (PTEN) (FRX) (HOG) Upgraded; (AN) (INTC) (TXT) Downgraded
-
Auriga on Renewable Technologies: Beyond Italy, Part 2
-
Auriga Maintains a 'Buy' on ReneSola Ltd. (SOL); When Better-Than-OK Just Isn't Good Enough
-
Auriga on Renewable Technologies: Guardedly Upbeat
-
Auriga Maintains a 'Buy' on ReneSola Ltd. (SOL); Poly Plant Continues to Ramp
-
Auriga Maintains a 'Buy/Top Pick' on ReneSola Ltd. (SOL); Low Cost Benchmark
-
Auriga Says Solar Sector Will "Retake the Skies" in 2012; Upgrades JA Solar (JASO), Canandian Solar (CSIQ) to Buy
-
Auriga Feels Shares of ReneSola Ltd. (SOL) Are Still Grossly Undervalued
-
Auriga Upgrades CSIQ, JASO to Buy, Downgrades SPWRA to Sell
-
Auriga Starts ReneSola Ltd. (SOL) at Buy; Undervalued Low-Cost Leader
-
Q3 Preview: Conservative JA Solar (JASO) Outlook May Be a Boon for Investors (LDK, STP, SOLF, SOL)

